A study to determine effective and tolerable titration scheme for OROS-Methylphenidate in Children with Attention-deficit hyperactivity disorder - Trial 2015-001070-18

Name: Clinical Trial 2015-001070-18
Creator: Janssen-Cilag Taiwan
Keywords: Attention Deficit Hyperactivity Disorder, clinical trial

Access comprehensive clinical trial information for 2015-001070-18 through Pure Global AI's free database. This phase not specified trial is sponsored by Janssen-Cilag Taiwan and is currently status unknown. The study focuses on Attention Deficit Hyperactivity Disorder.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2015-001070-18

Trial Details

EU Clinical Trials Register • 2015-001070-18

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

A study to determine effective and tolerable titration scheme for OROS-Methylphenidate in Children with Attention-deficit hyperactivity disorder

Study Focus

Disease/Condition

Attention Deficit Hyperactivity Disorder

Sponsor & Location

Primary Sponsor

Janssen-Cilag Taiwan

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

- Known to be non-responders to methylphenidate

ICD-10 Classifications

Neurotic disorder, unspecified

Hyperkinetic disorder, unspecified

Hyperkinetic disorders

Disorder of brain, unspecified

Hyperkinetic conduct disorder

Data Source

Registry

EU Clinical Trials Register

Trial ID

2015-001070-18

Type

Non-Device Trial